Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950123-01-002941
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
9
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 JOHNSON & JOHNSON y46182e10-k405.txt 10-K405 53438
2 2000 STOCK OPTION PLAN y46182ex10-b.txt EX-10.B 18065
3 2000 STOCK COMPENSATION PLAN y46182ex10-e.txt EX-10.E 2724
4 EXECUTIVE INCENTIVE PLAN y46182ex10-f.txt EX-10.F 12431
5 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS y46182ex12.txt EX-12 3441
6 PAGES OF THE COMPANY'S ANNUAL REPORT y46182ex13.txt EX-13 127956
7 SUBSIDIARIES y46182ex21.txt EX-21 17655
8 CONSENT OF INDEPENDENT ACCOUNTANTS y46182ex23.txt EX-23 1004
9 CAUTIONARY STATEMENT y46182ex99-b.txt EX-99.B 4967
  Complete submission text file 0000950123-01-002941.txt   244071
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 10-K405 | Act: 34 | File No.: 001-03215 | Film No.: 1586732
SIC: 2834 Pharmaceutical Preparations